Thyroid gland: US screening in a random adult population., Radiology, vol.181, issue.3, pp.683-690, 1991. ,
DOI : 10.1148/radiology.181.3.1947082
Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Archives of Internal Medicine, pp.1838-1878, 1994. ,
Incidence of thyroid cancer in adults recorded by French cancer registries (1978???1997), European Journal of Cancer, vol.38, issue.13, 2002. ,
DOI : 10.1016/S0959-8049(02)00110-7
Estimation nationale de l'incidence et de la mortalité par cancer en France entre, 1980. ,
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002, JAMA, vol.295, issue.18, pp.2164-2171, 1973. ,
DOI : 10.1001/jama.295.18.2164
Estimation de leur incidence et des facteurs de risque associés, 1994. ,
Non-medical exposure to radioiodines and thyroid cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.29, issue.S2, 2002. ,
DOI : 10.1007/s00259-002-0912-4
Prospective evaluation of thyroid imaging reporting and data system on 4550 nodules with and without elastography, European Journal of Endocrinology, vol.168, issue.5, pp.649-55, 2013. ,
DOI : 10.1530/EJE-12-0936
The Bethesda System for Reporting Thyroid Cytopathology, American Journal of Clinical Pathology, vol.132, issue.5, pp.658-65, 2009. ,
DOI : 10.1309/AJCPPHLWMI3JV4LA
Histological Typing of Thyroid Tumour, 1993. ,
DOI : 10.1007/978-3-642-61383-8
Progress in molecular-based management of differentiated thyroid cancer, The Lancet, vol.381, issue.9871, pp.1058-69, 2013. ,
DOI : 10.1016/S0140-6736(13)60109-9
TNM Classification of Malignant Tumours, 2009. ,
DOI : 10.1002/0471463752
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium, European Journal of Endocrinology, vol.154, issue.6, pp.787-803, 2006. ,
DOI : 10.1530/eje.1.02158
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid, vol.19, issue.11, pp.1167-214, 2009. ,
DOI : 10.1089/thy.2009.0110
Extent of Surgery Affects Survival for Papillary Thyroid Cancer. Annals of Surgery, pp.375-84, 2007. ,
Radioactive Iodine Lobe Ablation as an Alternative to Completion Thyroidectomy for Follicular Carcinoma of the Thyroid, Thyroid, vol.12, issue.11, pp.989-96, 2002. ,
DOI : 10.1089/105072502320908321
Postablation 131I scintigraphy with neck and thorax SPECT-CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer, European Journal of Endocrinology, vol.164, issue.6, pp.961-970, 2011. ,
DOI : 10.1530/EJE-11-0156
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer, The American Journal of Medicine, vol.97, issue.5, pp.418-446, 1994. ,
DOI : 10.1016/0002-9343(94)90321-2
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?, European Journal of Nuclear Medicine and Molecular Imaging, vol.30, issue.7, pp.974-81, 2003. ,
DOI : 10.1007/s00259-003-1174-5
Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.8, pp.2892-2901, 2006. ,
DOI : 10.1210/jc.2005-2838
URL : https://hal.archives-ouvertes.fr/hal-00176664
Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome, Endocrine Related Cancer, vol.14, issue.3, pp.799-807, 2007. ,
DOI : 10.1677/ERC-07-0120
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study, Clinical Endocrinology, vol.16, issue.1, pp.115-138, 2009. ,
DOI : 10.1111/j.1365-2265.2008.03424.x
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer, New England Journal of Medicine, vol.366, issue.18, pp.1663-73, 2012. ,
DOI : 10.1056/NEJMoa1108586
URL : https://hal.archives-ouvertes.fr/hal-00942194
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer, New England Journal of Medicine, vol.366, issue.18, pp.3661674-85 ,
DOI : 10.1056/NEJMoa1109589
Dosimetrically Determined Doses of Radioiodine for the Treatment of Metastatic Thyroid Carcinoma, Thyroid, vol.12, issue.2, pp.121-155, 2002. ,
DOI : 10.1089/105072502753522356
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer, Journal of Nuclear Medicine, vol.47, issue.10, pp.1587-91, 2006. ,
Lack of Efficacy of Recombinant Human Thyrotropin Versus Thyroid Hormone Withdrawal for Radioiodine Therapy Imaging in a Patient with Differentiated Thyroid Carcinoma Lung Metastases, Thyroid, vol.14, issue.6, pp.465-472, 2004. ,
DOI : 10.1089/105072504323150804
On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.154, issue.12, pp.2264-2270, 2010. ,
DOI : 10.1007/s00259-010-1608-9
Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, issue.12, 2010. ,
DOI : 10.1007/s00259-010-1565-3
Cancers de la thyroïde et traitement par iode 131. Medecine Nucleaire, pp.172-180, 2014. ,
DOI : 10.1016/j.mednuc.2014.03.132
Contrôle de qualité et mesure des performances des gamma-caméras. Rapport SFPM n°28 The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms, Journal of Nuclear Medicine, vol.42, issue.7, pp.998-1004, 2001. ,
Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. ? and molecular imaging, 2004. ,
SPECT/CT Evaluation of Unusual Physiologic Radioiodine Biodistributions: Pearls and Pitfalls in Image Interpretation, RadioGraphics, vol.33, issue.2, pp.397-418, 2013. ,
DOI : 10.1148/rg.332125051
Incremental Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma, Journal of Nuclear Medicine, vol.49, issue.12, 2008. ,
DOI : 10.2967/jnumed.108.052399
I Scintigraphy for Thyroid Cancer, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.6, pp.2075-84, 2009. ,
DOI : 10.1210/jc.2008-2313
Regional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT study, European Journal of Nuclear Medicine and Molecular Imaging, vol.19, issue.6, pp.1462-1468, 2010. ,
DOI : 10.1007/s00259-010-1408-2
Impact of 131I SPECT/Spiral CT on Nodal Staging of Differentiated Thyroid Carcinoma at the First Radioablation, Journal of Nuclear Medicine, vol.50, issue.1, pp.18-23, 2008. ,
DOI : 10.2967/jnumed.108.052746
Posttherapeutic 131I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen, European Journal of Nuclear Medicine and Molecular Imaging, vol.12, issue.6, pp.886-93, 2009. ,
DOI : 10.1007/s00259-008-1044-2
Preablation 131-I Scans With SPECT/CT in Postoperative Thyroid Cancer Patients: What Is the Impact on Staging? The Journal of Clinical Endocrinology & Metabolism, pp.1163-71, 2013. ,
Five months??? follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by 131I-SPECT/CT at the first radioablation, European Journal of Nuclear Medicine and Molecular Imaging, vol.36, issue.4, pp.699-705, 2009. ,
DOI : 10.1007/s00259-009-1299-2
Principe et technique de la tomographie par émission de positons (TEP). EMC -Radiologie, pp.2-35, 2003. ,
An Introduction to PET-CT Imaging1, RadioGraphics, 2004. ,
Biologie du FDG et des autres traceurs émetteurs de positons utilisés en cancérologie. Rev Acomen, 1998. ,
On the Origin of Cancer Cells. Science, Feb, vol.24123, issue.3191, pp.309-323, 1956. ,
Thyroid Cancer?Indications and TEP Abraham nuclear medicine, pp.121-159, 2011. ,
Influence of TSH on uptake of [18F] fluorodeoxyglucose in human thyroid cells in vitro Influence of rhTSH on [18 F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma, European journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine and Molecular Imaging, 2002. ,
-Glucose Positron Emission Tomography/Computed Tomography Imaging to Localize Residual Differentiated Thyroid Cancer, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.4, pp.1310-1316, 2009. ,
DOI : 10.1210/jc.2008-1747
URL : https://hal.archives-ouvertes.fr/hal-01160298
Clinical Utility of 18F-FDG PET/CT Concurrent with 131I Therapy in Intermediate-to-High-Risk Patients with Differentiated Thyroid Cancer: Dual-Center Experience with 286 Patients, Journal of Nuclear Medicine, vol.54, issue.8, pp.1230-1236, 2013. ,
DOI : 10.2967/jnumed.112.117119
Postradioiodine Treatment Whole-Body Scan in the Era of 18-Fluorodeoxyglucose Positron Emission Tomography for Differentiated Thyroid Carcinoma with Elevated Serum Thyroglobulin Levels, Thyroid, vol.22, issue.8, 2012. ,
DOI : 10.1089/thy.2012.0081
Correlation of 18F-FDG PET/CT Findings With Histopathological Results in Differentiated Thyroid Cancer Patients Who Have Increased Thyroglobulin or Antithyroglobulin Antibody Levels and Negative 131I Whole-Body Scan Results, Clinical Nuclear Medicine, vol.38, issue.5, pp.326-357, 2013. ,
DOI : 10.1097/RLU.0b013e318286827b
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management, Journal of Nuclear Medicine, vol.47, issue.4, pp.616-640, 2006. ,
Positron emission tomography and positron emission tomography-CT evaluation for r e c u r r e n t p a p i l l a r y t h y r o i d c a r c i n o m a : M e t a -analysis and literature review, Head Neck, pp.562-567, 2011. ,
Clinical impact of 18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy, Journal of Nuclear Medicine. Soc Nuclear Med, issue.10, pp.421464-421473, 2001. ,
Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.3, pp.1107-1120, 2000. ,
DOI : 10.1210/jc.85.3.1107
18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.9, issue.3, pp.1373-80, 2012. ,
DOI : 10.1007/s00259-012-2065-4
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer, New England Journal of Medicine, vol.368, issue.7, pp.623-655, 2013. ,
DOI : 10.1056/NEJMoa1209288
F-Fluorodeoxyglucose Positron Emission Tomography in Subjects without Cancer History, Korean Journal of Radiology, vol.14, issue.3, p.501, 2013. ,
DOI : 10.3348/kjr.2013.14.3.501
CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value 18-Fluorodeoxyglucose Positron Emission Tomography in the Early Diagnostic Workup of Differentiated Thyroid Cancer Patients with a Negative Post-Therapeutic Iodine Scan and Detectable Thyroglobulin, Endocrine. Thyroid, vol.4323, issue.38, pp.678-85, 2013. ,
Incremental Value of Diagnostic 131I SPECT/CT Fusion Imaging in the Evaluation of Differentiated Thyroid Carcinoma, American Journal of Roentgenology, vol.191, issue.6, pp.1785-94, 2008. ,
DOI : 10.2214/AJR.08.1218
I SPECT/CT, American Journal of Roentgenology, vol.195, issue.3, pp.730-736, 2010. ,
DOI : 10.2214/AJR.09.3458
131I SPECT/CT in the Follow-Up of Patients With Differentiated Thyroid Carcinoma, Clinical Nuclear Medicine, vol.37, issue.6, pp.555-60 ,
DOI : 10.1097/RLU.0b013e3182531dca
Cancer papillaire et??folliculaire de??la??thyro??de, Annales d'Endocrinologie, vol.68, issue.2-3, pp.120-128, 2007. ,
DOI : 10.1016/j.ando.2007.04.004
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome? Endocrine Related Cancer, pp.159-69, 2010. ,
18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.9, issue.3, pp.1373-80, 2012. ,
DOI : 10.1007/s00259-012-2065-4
Positron emission tomography-computed tomography with 18F-fluorodeoxyglucose in patients with recurrent differentiated thyroid carcinoma and negative radioiodine scan. Diagnostic performance and relation with thyroglobulin levels ,